Search for: "Rouse v. Georgia"
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
2 Apr 2012, 12:08 am
See Kemp v. [read post]
The manner of seizure for a mental health evaluation violated the Plaintiff’s fourth amendment right
19 Dec 2016, 6:55 am
The issue in May v. [read post]
The manner of seizure for a mental health evaluation violated the Plaintiff’s fourth amendment right
19 Dec 2016, 6:55 am
The issue in May v. [read post]
10 Aug 2012, 8:20 am
Hardwick), free speech (Texas v. [read post]
13 Jun 2023, 9:04 pm
After an unsuccessful direct appeal, United States v. [read post]
18 Apr 2024, 9:04 pm
After an unsuccessful direct appeal, United States v. [read post]
19 Mar 2018, 11:02 am
Board of Education or how we got to Obergefell v. [read post]
2 Nov 2009, 2:50 pm
" Video Link The People v. [read post]
17 Jun 2022, 12:40 pm
Bush v. [read post]
20 Aug 2009, 8:12 am
Michigan Ave., Suite 240Chicago, IL 60601Voice Phone (312)886-2359FAX (312)886-1807TDD (312)353-5693Region VI - Dallas (Arkansas, Louisiana, New Mexico, Oklahoma, Texas)Ralph Rouse, Regional ManagerOffice for Civil RightsU.S. [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
14 May 2021, 9:41 am
I really enjoyed The People v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
9 Mar 2023, 7:30 am
State v. [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), The latest edition of US Trade Representative’s ‘Special 301 Report’: (Ars Technica), (Ars Technica), (IAM), (Intellectual Property Watch), (Patry Copyright Blog), (Managing Intellectual Property), (Patent Docs), (IP Law360), Court rejects RIAA ‘making available’ theory: Atlantic v Howell:… [read post]
16 Apr 2015, 8:18 am
The Democratic National Convention that summer offered rousing endorsements of that right, and most Democratic senators announced support for it. [read post]
18 Apr 2008, 2:00 am
Protecting computer programs under the Copyright Act: Dais Studios v Bullet Creative: (IP Down Under), Assessing copyright risk in new classroom technologies: (IP Down Under), Cadbury loses battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law Blog), (IP Down Under), (IPKat), (IPwar’s), Employee or independent contractor? [read post]
4 Nov 2014, 11:36 am
It is perhaps unsurprising that some US politicians are using recent crises, such as the fight against ISIS and the spread of Ebola, to fear-monger and rouse their supporters. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
